Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Moretto R, Elliott A, Rossini D, Intini R, Conca V, Pietrantonio F, Sartore-Bianchi A, Antoniotti C, Rasola C, Scartozzi M, Salati M, Pella N, Calegari MA, Carullo M, Corti F, Mauri G, Fassan M, Masi G, Brodskiy P, Lenz HJ, Shields A, Lonardi S, Korn M, Cremolini C.
Moretto R, et al. Among authors: brodskiy p.
Br J Cancer. 2022 Sep;127(5):957-967. doi: 10.1038/s41416-022-01852-0. Epub 2022 Jun 3.
Br J Cancer. 2022.
PMID: 35665778
Free PMC article.